Ansbert Gadicke - Insider Trading & Ownership

Location
399 Boylston Street, Suite 1100, Boston, MA
Summary
The estimated net worth of Ansbert Gadicke is at least $301M dollars as of December 4, 2025. Ansbert Gadicke is the 10%+ Owner of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. stock worth about $146M. Ansbert Gadicke is the Director of Cullinan Oncology, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $103M. Ansbert Gadicke is the Former 10% Owner of iTeos Therapeutics, Inc. and owns shares of iTeos Therapeutics, Inc. (ITOS) stock worth about $27.8M. Ansbert Gadicke is the Director, 10%+ Owner of Allovir, Inc. and owns shares of Kalaris Therapeutics, Inc. (KLRS) stock worth about $11.2M. Ansbert Gadicke is the 10%+ Owner of Repare Therapeutics Inc. and owns shares of Repare Therapeutics Inc. (RPTX) stock worth about $9.42M. Ansbert Gadicke is the Former 10% Owner of Werewolf Therapeutics, Inc. and owns shares of Werewolf Therapeutics, Inc. (HOWL) stock worth about $4.64M.
Signature
/s/ Ansbert Gadicke, Manager of MPM Oncology Innovations Fund GP LLC, the GP of MPM Oncology Innovations Fund, L.P.
All Insider Reports
All Insider Reports

Ownership of Ansbert Gadicke

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HARP Harpoon Therapeutics, Inc. 10%+ Owner $146M May 28, 2021
CGEM Cullinan Therapeutics, Inc. Director $103M Jun 22, 2022
ITOS iTeos Therapeutics, Inc. Former 10% Owner $27.8M -$8.32M -23% May 13, 2025
KLRS Kalaris Therapeutics, Inc. Director, 10%+ Owner $11.2M Jul 28, 2022
RPTX Repare Therapeutics Inc. 10%+ Owner $9.42M Jul 9, 2021
HOWL Werewolf Therapeutics, Inc. Former 10% Owner $4.64M -$2.23M -32.4% Dec 2, 2025
TCRR TCR2 THERAPEUTICS INC. Director, 10%+ Owner Jun 1, 2023

Insider Transactions Reported by Ansbert Gadicke:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.